Medacta Group SA (MEDGF) Q4 2025 Sales/Trading Call Transcript
Seeking Alpha·2026-02-03 17:20
Core Insights - Medacta reported a preliminary unaudited revenue of slightly above EUR 683 million for the full year 2025, achieving a growth rate of over 18.5% in constant currency [4]. Group 1: Growth Performance - The company experienced outstanding growth across all geographic markets and business lines, indicating strong overall performance compared to the previous year [3]. - Key drivers of this growth include a strong focus on innovative products, effective medical education, and an expanding workforce, with 258 new employees hired last year [4].